FORNARI, FRANCESCA
FORNARI, FRANCESCA
QUVI - DIPARTIMENTO DI SCIENZE PER LA QUALITA' DELLA VITA
Docenti di ruolo di IIa fascia
Early CTLA4 increase in CD45+ blood cells: an emerging biomarker of atezolizumab–bevacizumab resistance and worse survival in advanced hepatocarcinoma
2025 Gramantieri, L.; Montagner, A.; Arleo, A.; Suzzi, F.; Bassi, C.; Tovoli, F.; Bruccoleri, M.; Alimenti, E.; Fornari, F.; Iavarone, M.; Negrini, M.; Piscaglia, F.; Giovannini, C.
Gut microbiome alterations and lenvatinib resistance in hepatocellular carcinoma: the role of Akkermansia muciniphila postbiotics in treatment enhancement
2025 Monti, Elisa; Galvani, Giuseppe; Leoni, Ilaria; Vianello, Clara; Bella, Marco; D’Amico, Federica; Roggiani, Sara; Elena Cifarelli, Maria; Marinelli, Sara; Giovannini, Catia; Gramantieri, Laura; Stefanelli, Claudio; Turroni, Silvia; Fornari, Francesca
Gut Microbiome Modulation in Hepatocellular Carcinoma: Preventive Role in NAFLD/NASH Progression and Potential Applications in Immunotherapy-Based Strategies
2025 Monti, E.; Vianello, C.; Leoni, I.; Galvani, G.; Lippolis, A.; D'Amico, F.; Roggiani, S.; Stefanelli, C.; Turroni, S.; Fornari, F.
MiR-22/GLUT1 Axis Induces Metabolic Reprogramming and Sorafenib Resistance in Hepatocellular Carcinoma
2025 Leoni, Ilaria; Galvani, Giuseppe; Monti, Elisa; Vianello, Clara; Valenti, Francesca; Pincigher, Luca; Grolla, Ambra A; Moro, Marianna; Coada, Camelia A; Perrone, Alessandro; Righi, Valeria; Marinelli, Sara; Ravegnini, Gloria; Giovannini, Catia; Baldassarre, Maurizio; Pariali, Milena; Ravaioli, Matteo; Cescon, Matteo; Vasuri, Francesco; Domenicali, Marco; Negrini, Massimo; Piscaglia, Fabio; Fato, Romana; Stefanelli, Claudio; Gramantieri, Laura; Bergamini, Christian; Fornari, Francesca
Mir-30e-3p/CXCL3 axis is involved in sorafenib resistance of hepatocellular carcinoma through the modulation of the tumor immune microenvironment
2025 Leoni, Ilaria; Vianello, Clara; Monti, Elisa; Galvani, Giuseppe; Bella, Marco; Coada, Camelia Alexandra; Amy, Collins; Erik, Ramon-Gil; Ravegnini, Gloria; Piscaglia, Fabio; Stefanelli, Claudio; Gramantieri, Laura; Jack, Leslie; Mann Derek, A.; Fornari, Francesca
miR-30e-3p/CXCL3 axis predicts early tumor escape in hepatocellular carcinoma patients undergoing sorafenib treatment
2025 Monti, Elisa; Vianello, Clara; Leoni, Ilaria; Galvani, Giuseppe; Marinelli, Sara; Marisi, Giorgia; Casadei Giardini, Andrea; Giuseppe Foschi, Francesco; Giovannini1, Catia; Piscaglia, Fabio; Negrini, Massimo; Stefanelli, Claudio; Gramantieri, Laura; Fornari, Francesca
miR-30e-3p/CXCL3 axis predicts early tumor escape in sorafenib-treated hepatocellular carcinoma patients.
2025 Vianello, Clara; Leoni, Ilaria; Galvani, Giuseppe; Monti, Elisa; Marinelli, Sara; Marisi, Giorgia; Casadei Giardini, Andrea; Giuseppe Foschi, Francesco; Giovannini, Catia; 3, ; Piscaglia, Fabio; Negrini, Massimo; Stefanelli, Claudio; Gramantieri, Laura; Fornari, Francesca
Circulating CD8 lymphocytes predict response to atezolizumab–bevacizumab in hepatocellular carcinoma
2024 Gramantieri L.; Suzzi F.; Bassi C.; D'Abundo L.; Tovoli F.; Bruccoleri M.; Marseglia M.; Alimenti E.; Fornari F.; Negrini M.; Iavarone M.; Piscaglia F.; Giovannini C.
CXCL3 is a target of miR-30e-3p and predicts tumor escape in sorafenib-treated HCC patients.
2024 Vianello, C.; Leoni, I.; Galvani, G.; Monti, E.; Marinelli, S.; Marisi, G.; Casadei Gardini, A.; Foschi, G. F.; Giovannini, C.; Ravaioli, M.; Cescon, M.; Vasuri, F.; Negrini, M.; Piscaglia, F.; Stefanelli, C.; Gramantieri, L.; Fornari, F.
MiR-22 downregulation activates HIF-1A pathway and induces tumour progression, metabolic reprogramming and sorafenib resistance in hepatocellular carcinoma
2024 Leoni, Ilaria; Galvani, Giuseppe; Monti, Elisa; Vianello, Clara; Valenti, Francesca; Marinelli, Sara; Giovannini, Catia; Baldassarre, Maurizio; Ravaioli, Matteo; Cescon, Matteo; Vasuri, Francesco; Domenicali, Marco; Negrini, Massimo; Piscaglia, Fabio; Fato, Romana; Stefanelli, Claudio; Gramantieri, Laura; Bergamini, Christian; Fornari, Francesca
miR-30e-3p/CXCL3 axis predicts early tumor escape in sorafenib-treated HCC patients.
2024 Vianello, C.; Leoni, I.; Galvani, G.; Monti, E.; Marisi, G.; Casadei Gardini, A.; Foschi, G. F.; Stefanelli, C.; Gramantieri, L.; Fornari, F.
Noncoding RNAs in Hepatocellular Carcinoma: Potential Applications in Combined Therapeutic Strategies and Promising Candidates of Treatment Response
2024 Clara Vianello, Elisa Monti, Ilaria Leoni, Giuseppe Galvani, Catia Giovannini, Fabio Piscaglia, Claudio Stefanelli, Laura Gramantieri, Francesca Fornari
The tumour suppressor miR-22 induces metabolic reprogramming through GLUT1 targeting and represents a possible biomarker of Sorafenib response in Hepatocellular Carcinoma
2024 Leoni, Ilaria; Galvani, Giuseppe; Monti, Elisa; Vianello, Clara; Valenti, Francesca; Pincigher, Luca; Marinelli, Sara; Ravegnini, Gloria; Giovannini, Catia; Ravaioli, Matteo; Cescon, Matteo; Vasuri, Francesco; Negrini, Massimo; Piscaglia, Fabio; Fato, Romana; Stefanelli, Claudio; Gramantieri, Laura; Bergamini, Christian; Fornari, Francesca
Towards precision medicine: a preliminary collection of patient-derived organoids for the screening of personalised therapies in hepatocellular carcinoma
2024 Monti, Elisa; Leoni, Ilaria; Galvani, Giuseppe; Vianello, Clara; Giovannini, Catia; Vasuri, Francesco; Piscaglia, Fabio; Stefanelli, Claudio; Gramantieri, Laura; Fornari, Francesca
Low-Baseline PD1+ Granulocytes Predict Responses to Atezolizumab–Bevacizumab in Hepatocellular Carcinoma
2023 Giovannini, Catia; Suzzi, Fabrizia; Tovoli, Francesco; Bruccoleri, Mariangela; Marseglia, Mariarosaria; Alimenti, Eleonora; Fornari, Francesca; Iavarone, Massimo; Piscaglia, Fabio; Gramantieri, Laura
MiR-494 induces metabolic changes through G6pc targeting and modulates sorafenib response in hepatocellular carcinoma
2023 Bergamini, Christian; Leoni, Ilaria; Rizzardi, Nicola; Melli, Mattia; Galvani, Giuseppe; Coada, Camelia Alexandra; Giovannini, Catia; Monti, Elisa; Liparulo, Irene; Valenti, Francesca; Ferracin, Manuela; Ravaioli, Matteo; Cescon, Matteo; Vasuri, Francesco; Piscaglia, Fabio; Negrini, Massimo; Stefanelli, Claudio; Fato, Romana; Gramantieri, Laura; Fornari, Francesca
MiR-494 induces metabolic reprogramming through G6pc targeting and modulates sorafenib response in hepatocellular carcinoma
2023 Leoni, Ilaria; Galvani, Giuseppe; Bergamini, Christian; Rizzardi, Nicola; Melli, Mattia; Coada, Camelia Alexandra; Monti, Elisa; Giovannini, Catia; Liparulo, Irene; Ferracin, Manuela; Ravaioli, Matteo; Cescon, Matteo; Vasuri, Francesco; Piscaglia, Fabio; Negrini, Massimo; Stefanelli, Claudio; Fato, Romana; Gramantieri, Laura; Fornari, Francesca
Aflatoxin B1 DNA-Adducts in Hepatocellular Carcinoma from a Low Exposure Area
2022 Gramantieri L.; Gnudi F.; Vasuri F.; Mandrioli D.; Fornari F.; Tovoli F.; Suzzi F.; Vornoli A.; D'errico A.; Piscaglia F.; Giovannini C.
Animal Models of Hepatocellular Carcinoma: Current Applications in Clinical Research
2022 Francesca Fornari; Catia Giovannini; Fabio Piscaglia; Laura Gramantieri
MicroRNA as predictive biomarkers of treatment response to tyrosine kinase inhibitors in hepatocellular carcinoma: how much is missing?
2022 Gramantieri, Laura; Fornari, Francesca
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Early CTLA4 increase in CD45+ blood cells: an emerging biomarker of atezolizumab–bevacizumab resistance and worse survival in advanced hepatocarcinoma | Gramantieri, L.; Montagner, A.; Arleo, A.; Suzzi, F.; Bassi, C.; Tovoli, F.; Bruccoleri, M.; Alim...enti, E.; Fornari, F.; Iavarone, M.; Negrini, M.; Piscaglia, F.; Giovannini, C. | 2025-01-01 | ESMO OPEN | - | 1.01 Articolo in rivista | Early CTLA4 increase in CD45+ blood cells_ an emerging biomarker of atezolizumab-bevacizumab resistance and worse survival in advanced hepatocarcinoma.pdf; mmc1.docx |
| Gut microbiome alterations and lenvatinib resistance in hepatocellular carcinoma: the role of Akkermansia muciniphila postbiotics in treatment enhancement | Monti, Elisa; Galvani, Giuseppe; Leoni, Ilaria; Vianello, Clara; Bella, Marco; D’Amico, Federica;... Roggiani, Sara; Elena Cifarelli, Maria; Marinelli, Sara; Giovannini, Catia; Gramantieri, Laura; Stefanelli, Claudio; Turroni, Silvia; Fornari, Francesca | 2025-01-01 | - | - | 4.03 Poster | - |
| Gut Microbiome Modulation in Hepatocellular Carcinoma: Preventive Role in NAFLD/NASH Progression and Potential Applications in Immunotherapy-Based Strategies | Monti, E.; Vianello, C.; Leoni, I.; Galvani, G.; Lippolis, A.; D'Amico, F.; Roggiani, S.; Stefane...lli, C.; Turroni, S.; Fornari, F. | 2025-01-01 | CELLS | - | 1.01 Articolo in rivista | cells-14-00084-v2.pdf |
| MiR-22/GLUT1 Axis Induces Metabolic Reprogramming and Sorafenib Resistance in Hepatocellular Carcinoma | Leoni, Ilaria; Galvani, Giuseppe; Monti, Elisa; Vianello, Clara; Valenti, Francesca; Pincigher, L...uca; Grolla, Ambra A; Moro, Marianna; Coada, Camelia A; Perrone, Alessandro; Righi, Valeria; Marinelli, Sara; Ravegnini, Gloria; Giovannini, Catia; Baldassarre, Maurizio; Pariali, Milena; Ravaioli, Matteo; Cescon, Matteo; Vasuri, Francesco; Domenicali, Marco; Negrini, Massimo; Piscaglia, Fabio; Fato, Romana; Stefanelli, Claudio; Gramantieri, Laura; Bergamini, Christian; Fornari, Francesca | 2025-01-01 | INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | - | 1.01 Articolo in rivista | ijms-26-03808-s001.zip; ijms-26-03808+(1)_compressed.pdf |
| Mir-30e-3p/CXCL3 axis is involved in sorafenib resistance of hepatocellular carcinoma through the modulation of the tumor immune microenvironment | Leoni, Ilaria; Vianello, Clara; Monti, Elisa; Galvani, Giuseppe; Bella, Marco; Coada, Camelia Ale...xandra; Amy, Collins; Erik, Ramon-Gil; Ravegnini, Gloria; Piscaglia, Fabio; Stefanelli, Claudio; Gramantieri, Laura; Jack, Leslie; Mann Derek, A.; Fornari, Francesca | 2025-01-01 | - | - | 4.03 Poster | - |
| miR-30e-3p/CXCL3 axis predicts early tumor escape in hepatocellular carcinoma patients undergoing sorafenib treatment | Monti, Elisa; Vianello, Clara; Leoni, Ilaria; Galvani, Giuseppe; Marinelli, Sara; Marisi, Giorgia...; Casadei Giardini, Andrea; Giuseppe Foschi, Francesco; Giovannini1, Catia; Piscaglia, Fabio; Negrini, Massimo; Stefanelli, Claudio; Gramantieri, Laura; Fornari, Francesca | 2025-01-01 | - | - | 4.03 Poster | - |
| miR-30e-3p/CXCL3 axis predicts early tumor escape in sorafenib-treated hepatocellular carcinoma patients. | Vianello, Clara; Leoni, Ilaria; Galvani, Giuseppe; Monti, Elisa; Marinelli, Sara; Marisi, Giorgia...; Casadei Giardini, Andrea; Giuseppe Foschi, Francesco; Giovannini, Catia; 3, ; Piscaglia, Fabio; Negrini, Massimo; Stefanelli, Claudio; Gramantieri, Laura; Fornari, Francesca | 2025-01-01 | - | - | 4.03 Poster | - |
| Circulating CD8 lymphocytes predict response to atezolizumab–bevacizumab in hepatocellular carcinoma | Gramantieri L.; Suzzi F.; Bassi C.; D'Abundo L.; Tovoli F.; Bruccoleri M.; Marseglia M.; Alimenti... E.; Fornari F.; Negrini M.; Iavarone M.; Piscaglia F.; Giovannini C. | 2024-01-01 | EUROPEAN JOURNAL OF IMMUNOLOGY | - | 1.01 Articolo in rivista | Eur J Immunol - 2023 - Gramantieri - Circulating CD8 lymphocytes predict respo.pdf; eji5648-sup-0001-suppmat.pdf |
| CXCL3 is a target of miR-30e-3p and predicts tumor escape in sorafenib-treated HCC patients. | Vianello, C.; Leoni, I.; Galvani, G.; Monti, E.; Marinelli, S.; Marisi, G.; Casadei Gardini, A.; ...Foschi, G. F.; Giovannini, C.; Ravaioli, M.; Cescon, M.; Vasuri, F.; Negrini, M.; Piscaglia, F.; Stefanelli, C.; Gramantieri, L.; Fornari, F. | 2024-01-01 | - | - | 4.03 Poster | - |
| MiR-22 downregulation activates HIF-1A pathway and induces tumour progression, metabolic reprogramming and sorafenib resistance in hepatocellular carcinoma | Leoni, Ilaria; Galvani, Giuseppe; Monti, Elisa; Vianello, Clara; Valenti, Francesca; Marinelli, S...ara; Giovannini, Catia; Baldassarre, Maurizio; Ravaioli, Matteo; Cescon, Matteo; Vasuri, Francesco; Domenicali, Marco; Negrini, Massimo; Piscaglia, Fabio; Fato, Romana; Stefanelli, Claudio; Gramantieri, Laura; Bergamini, Christian; Fornari, Francesca | 2024-01-01 | - | - | 4.03 Poster | - |
| miR-30e-3p/CXCL3 axis predicts early tumor escape in sorafenib-treated HCC patients. | Vianello, C.; Leoni, I.; Galvani, G.; Monti, E.; Marisi, G.; Casadei Gardini, A.; Foschi, G. F.; ...Stefanelli, C.; Gramantieri, L.; Fornari, F. | 2024-01-01 | - | - | 4.03 Poster | - |
| Noncoding RNAs in Hepatocellular Carcinoma: Potential Applications in Combined Therapeutic Strategies and Promising Candidates of Treatment Response | Clara Vianello, Elisa Monti, Ilaria Leoni, Giuseppe Galvani, Catia Giovannini, Fabio Piscaglia, C...laudio Stefanelli, Laura Gramantieri, Francesca Fornari | 2024-01-01 | CANCERS | - | 1.01 Articolo in rivista | Vianello cancers-16-00766_2024.pdf |
| The tumour suppressor miR-22 induces metabolic reprogramming through GLUT1 targeting and represents a possible biomarker of Sorafenib response in Hepatocellular Carcinoma | Leoni, Ilaria; Galvani, Giuseppe; Monti, Elisa; Vianello, Clara; Valenti, Francesca; Pincigher, L...uca; Marinelli, Sara; Ravegnini, Gloria; Giovannini, Catia; Ravaioli, Matteo; Cescon, Matteo; Vasuri, Francesco; Negrini, Massimo; Piscaglia, Fabio; Fato, Romana; Stefanelli, Claudio; Gramantieri, Laura; Bergamini, Christian; Fornari, Francesca | 2024-01-01 | - | - | 4.01 Contributo in Atti di convegno | - |
| Towards precision medicine: a preliminary collection of patient-derived organoids for the screening of personalised therapies in hepatocellular carcinoma | Monti, Elisa; Leoni, Ilaria; Galvani, Giuseppe; Vianello, Clara; Giovannini, Catia; Vasuri, Franc...esco; Piscaglia, Fabio; Stefanelli, Claudio; Gramantieri, Laura; Fornari, Francesca | 2024-01-01 | - | - | 4.03 Poster | - |
| Low-Baseline PD1+ Granulocytes Predict Responses to Atezolizumab–Bevacizumab in Hepatocellular Carcinoma | Giovannini, Catia; Suzzi, Fabrizia; Tovoli, Francesco; Bruccoleri, Mariangela; Marseglia, Mariaro...saria; Alimenti, Eleonora; Fornari, Francesca; Iavarone, Massimo; Piscaglia, Fabio; Gramantieri, Laura | 2023-01-01 | CANCERS | - | 1.01 Articolo in rivista | Cancers 2023.pdf |
| MiR-494 induces metabolic changes through G6pc targeting and modulates sorafenib response in hepatocellular carcinoma | Bergamini, Christian; Leoni, Ilaria; Rizzardi, Nicola; Melli, Mattia; Galvani, Giuseppe; Coada, C...amelia Alexandra; Giovannini, Catia; Monti, Elisa; Liparulo, Irene; Valenti, Francesca; Ferracin, Manuela; Ravaioli, Matteo; Cescon, Matteo; Vasuri, Francesco; Piscaglia, Fabio; Negrini, Massimo; Stefanelli, Claudio; Fato, Romana; Gramantieri, Laura; Fornari, Francesca | 2023-01-01 | JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH | - | 1.01 Articolo in rivista | miR-494 metabolism.pdf; 23498179.zip |
| MiR-494 induces metabolic reprogramming through G6pc targeting and modulates sorafenib response in hepatocellular carcinoma | Leoni, Ilaria; Galvani, Giuseppe; Bergamini, Christian; Rizzardi, Nicola; Melli, Mattia; Coada, C...amelia Alexandra; Monti, Elisa; Giovannini, Catia; Liparulo, Irene; Ferracin, Manuela; Ravaioli, Matteo; Cescon, Matteo; Vasuri, Francesco; Piscaglia, Fabio; Negrini, Massimo; Stefanelli, Claudio; Fato, Romana; Gramantieri, Laura; Fornari, Francesca | 2023-01-01 | - | - | 4.03 Poster | - |
| Aflatoxin B1 DNA-Adducts in Hepatocellular Carcinoma from a Low Exposure Area | Gramantieri L.; Gnudi F.; Vasuri F.; Mandrioli D.; Fornari F.; Tovoli F.; Suzzi F.; Vornoli A.; D...'errico A.; Piscaglia F.; Giovannini C. | 2022-01-01 | NUTRIENTS | - | 1.01 Articolo in rivista | 86. adducts.pdf; nutrients-14-01652-s001.zip |
| Animal Models of Hepatocellular Carcinoma: Current Applications in Clinical Research | Francesca Fornari; Catia Giovannini; Fabio Piscaglia; Laura Gramantieri | 2022-01-01 | JOURNAL OF HEPATOCELLULAR CARCINOMA | - | 1.01 Articolo in rivista | JHC-347946-animal-models-of-hepatocellular-carcinoma--current-applicati.pdf |
| MicroRNA as predictive biomarkers of treatment response to tyrosine kinase inhibitors in hepatocellular carcinoma: how much is missing? | Gramantieri, Laura; Fornari, Francesca | 2022-01-01 | ONCOSCIENCE | - | 1.04 Replica / breve intervento (e simili) | oncoscience-v9-564.pdf |